ARCHIVES

New Saccharin Studies Convince FDA It A Carcinogen

This article is from The Cancer Letter archive.

Vol. 03 No. 28 | July 15, 1977

Download PDF Visit The Full Archive

Related Articles

Ontak Approved For Lymphoma

October 31, 2008

Give New Investigators “Special Consideration,” Advisors Tell NCI

June 28, 2002

House Approves $619M Increase For NIH.

February 2, 2007

DCT Board Approves Management Support, Drug Storage Concepts

March 3, 1989

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011